German Chemical Producers Lower 2014 Forecast

Germany's chemical industry association, Verband der Chemischen Industrie (VCI), has adjusted downward its full-year 2014 business outlook following a weaker than expected second quarter.

Led by base chemicals, overall production deteriorated by 2.3% in Q2 2014 against Q1, figures show, although output was still 0.3% higher than in the 2013 quarter. Capacity utilization rates held up at 84%.

The association now forecasts an increase in annual chemical production of only 1.5%, compared with the 2% expected earlier this year. With prices expected to fall by 1% year-in-year, industry-wide turnover should increase by 1% to €192.5 billion, VCI said. This contrasts with earlier predictions of a 1.5% sales rise.

VCI president, Karl-Ludwig Kley, who is also CEO of Merck KGaA, said business in both domestic and foreign reacted to negative geopolitical trends in the second quarter. Falling GDP growth in core eurozone markets such as France and Italy burdened trading, while the traditionally weaker economies of Spain, Portugal and Greece fared somewhat better.

Alongside the softness abroad, business with domestic customers was less dynamic, as these reacted to the rising export risk by lowering order volume.

Across the chemical and pharmaceutical sectors, sales revenue dipped by 1.2% in Q2 against Q1 to €45.8 billion. In the same time frame, domestic sales fell by 2.8% to €17.8 billion, and foreign sales eroded by 0.9% to €28 billion across all geographies.

But even if business is not likely to bounce back to last year's level, Kley said chemical producers "expect a modest recovery in demand in the second half of the year, if the geopolitical situation doesn't deteriorate further."

 

Company

Logo:

VCI Verband Chem.- Ind. e.V

Mainzer Landstr. 55
60329 Frankfurt
Germany

Company contact







Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read